Related Experiment Video
Updated: Jun 22, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Acute ischemic stroke in a pediatric patient
Julie Gorchynski1, John Herrick, Edgar Cortes
1CHRISTUS Spohn Memorial Hospital, Texas A&M, Department of Emergency Medicine.
Insights
Pediatric acute ischemic stroke is complex and differs from adults. Consult specialists before using anti-thrombotic therapy due to unclear benefits and risks in children.
Area of Science:
- Neurology
- Pediatrics
- Vascular Medicine
Background:
- Pediatric acute ischemic stroke (AIS) presents unique etiologies distinct from adult presentations.
- While rare, AIS in children can lead to severe, long-term consequences.
- Current literature on AIS management in pediatric patients is limited, comprising case reports and retrospective reviews, yielding conflicting outcomes.
Purpose of the Study:
- To review the current understanding of pediatric acute ischemic stroke.
- To outline emergency department management strategies for pediatric AIS.
- To address the use of anti-thrombotic therapy in pediatric AIS.
Main Methods:
- Literature review of case reports and retrospective database studies.
- Analysis of emergency department management protocols.
- Discussion of anti-thrombotic drug therapy (anti-platelets, thrombolytics) in pediatric AIS.
Main Results:
- Pediatric AIS has varied etiologies and potentially devastating outcomes.
- Anti-thrombotic drug therapy is being used, but its benefits remain unclear.
- Conflicting outcomes reported in existing literature complicate treatment decisions.
Conclusions:
- Emergency management of pediatric AIS requires immediate pediatric neurologist and intensivist consultation.
- Stabilization and resuscitation are critical initial steps.
- Anti-thrombotic therapy decisions should be made in consultation with specialists pending further randomized controlled trials on safety and efficacy in pediatric populations.
Abstract:
Acute ischemic stroke in a pediatric patient is a complex disease with a variety of etiologies that differ from adults. Though rare, they are a real phenomenon with potentially devastating consequences. Some treating institutions are using anti-thrombotic drug therapy with unclear benefits. Available literature, which is limited to case reports and retrospective reviews of databases, clouds this topic with both positive and negative outcomes. Emergency department management should focus on stabilization and resuscitation with immediate involvement of a pediatric neurologist and intensivist. The decision to use anti-thrombotic drug therapy, including anti-platelet drugs and thrombolytics, should be in consult with the specialists involved until randomized controlled trials determine their safety and efficacy in the pediatric population.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Stroke: Introduction and Types
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

